Dis-Chem Pharmacies

DCP · JSE · Healthcare / Pharmaceutical Retailers

2,342.00ZAC-32.00 (-1.35%)

Price History

Full chart

Market Stats

Previous Close2,374.00

Open2,450.00

Day Range2,342.00 – 2,450.00

52-Week Range2,535.00 – 3,881.06

Volume416.56K

Market Cap23.29B

P/E (TTM)23.87

Forward P/E0.00

EPS1.14

Dividend Yield1.17%

Beta0.29

50-Day Avg2,824.46

200-Day Avg3,346.75

About

Dis-Chem Pharmacies Limited, together with its subsidiaries, engages in the retail and wholesale of healthcare products and pharmaceuticals in South Africa. The company operates through two segments: Retail and Wholesale. It owns and operates a chain of retail stores that offers various products, including dispensaries, personal care and beauty, healthcare and nutrition, baby care, and other products. The company also provides pharmaceutical, health, and front shop products in the wholesale market, health insurance products, occupational health clinics, and a psychological wellbeing platform. In addition, it offers customer loyalty programs. The company was founded in 1978 and is headquartered in Midrand, South Africa.

Company Details

SectorHealthcare
IndustryPharmaceutical Retailers
CEOMr. Rui Manuel Morais C.A.
Employees0
Headquarters23 Stag Road, Midrand, South Africa, 1682, South Africa
Websitehttps://dischemgroup.com

Leadership

Mr. Rui Manuel Morais C.A.CEO & Executive Director · b. 1984
Ms. Julia Denise PopeCFO & Executive Director
Christopher J. WilliamsPrescribed Officer
Ms. Nikki J. LumleyCompany Secretary
C. A. SwanepoelPrescribed Officer
T. J. PonterPrescribed Officer

Financials

Income Statement

Currency: ZAR	2014-02-28	2015-02-28	2016-02-29	2017-02-28	2018-02-28	2019-02-28	2020-02-29	2021-02-28	2022-02-28	2023-02-28	2024-02-29	2025-02-28	2026-02-28
Total Revenue	10.32B	12.91B	15.06B	17.27B	19.56B	21.42B	23.98B	26.28B	30.41B	32.66B	36.28B	39.17B	42.83B
Growth (%)	-	+25.09%	+16.66%	+14.65%	+13.27%	+9.51%	+11.97%	+9.56%	+15.71%	+7.42%	+11.08%	+7.96%	+9.33%
Cost of Revenue	7.85B	9.92B	11.53B	13.06B	14.79B	16.20B	18.43B	20.44B	23.58B	25.08B	28.07B	30.37B	34.68B
Gross Profit	2.48B	2.99B	3.53B	4.21B	4.77B	5.22B	5.56B	5.84B	6.83B	7.59B	8.22B	8.80B	8.15B
Gross Margin	23.99%	23.19%	23.42%	24.38%	24.38%	24.38%	23.16%	22.21%	22.46%	23.23%	22.65%	22.47%	19.03%
Operating Expense	1.86B	2.32B	2.62B	3.08B	3.64B	4.00B	4.31B	4.57B	5.29B	5.84B	6.44B	6.70B	6.16B
Operating Income	610.89M	676.45M	906.68M	1.13B	1.13B	1.22B	1.25B	1.27B	1.54B	1.74B	1.78B	2.10B	1.99B
Operating Margin	5.92%	5.24%	6.02%	6.52%	5.75%	5.69%	5.21%	4.82%	5.06%	5.34%	4.90%	5.37%	4.66%
EBITDA	722.99M	805.24M	1.06B	1.31B	1.37B	1.93B	1.85B	1.99B	2.39B	2.75B	2.91B	3.30B	3.25B
EBITDA Margin	7.01%	6.24%	7.07%	7.57%	7.03%	9.01%	7.70%	7.57%	7.87%	8.41%	8.03%	8.42%	7.60%
Net Income	408.59M	433.65M	512.77M	612.35M	684.28M	734.72M	598.23M	668.69M	853.45M	1.00B	984.48M	1.18B	978.89M
Net Income Margin	3.96%	3.36%	3.40%	3.55%	3.50%	3.43%	2.49%	2.54%	2.81%	3.06%	2.71%	3.01%	2.29%
Interest Expense	8.75M	25.48M	96.47M	249.22M	188.40M	364.97M	402.05M	417.49M	418.02M	486.14M	586.01M	645.92M	695.58M
Interest Expense % of Total Revenue	0.08%	0.20%	0.64%	1.44%	0.96%	1.70%	1.68%	1.59%	1.37%	1.49%	1.62%	1.65%	1.62%

Balance Sheet

Currency: ZAR	2014-02-28	2015-02-28	2016-02-29	2017-02-28	2018-02-28	2019-02-28	2020-02-29	2021-02-28	2022-02-28	2023-02-28	2024-02-29	2025-02-28	2026-02-28
Total Assets	2.96B	3.53B	5.17B	5.90B	7.13B	8.84B	10.59B	13.19B	14.08B	15.52B	17.50B	19.26B	20.74B
Total Liabilities	1.95B	2.23B	4.33B	4.77B	5.44B	6.73B	8.27B	10.24B	10.69B	11.58B	13.03B	14.03B	15.04B
Total Equity	941.51M	1.22B	722.57M	1.11B	1.63B	2.04B	2.25B	2.91B	3.32B	3.90B	4.47B	5.22B	5.64B
Cash	23.34M	26.95M	273.21M	294.70M	280.00M	177.43M	451.84M	539.73M	705.85M	287.38M	884.37M	585.35M	499.76M
Total Debt	604.97M	755.16M	2.38B	1.79B	1.87B	2.09B	3.70B	4.48B	4.51B	4.97B	5.69B	6.24B	6.64B
Net Debt	581.63M	728.21M	2.11B	1.50B	1.59B	1.91B	3.25B	3.94B	3.80B	4.69B	4.81B	5.65B	6.14B

Cash Flow

Currency: ZAR	2014-02-28	2015-02-28	2016-02-29	2017-02-28	2018-02-28	2019-02-28	2020-02-29	2021-02-28	2022-02-28	2023-02-28	2024-02-29	2025-02-28	2026-02-28
Operating Cash Flow	51.90M	-234.98M	-668.31M	159.16M	45.02M	336.04M	1.26B	1.12B	1.38B	853.94M	1.89B	904.70M	2.32B
Investing Cash Flow	-199.65M	-211.37M	-142.89M	-221.54M	-249.63M	-549.72M	-413.22M	-779.75M	-795.56M	-1.09B	-1.06B	-1.50B	-1.23B
Financing Cash Flow	176.71M	38.68M	-1.04B	1.45B	-174.17M	-239.99M	-61.44M	-498.13M	-444.61M	-203.15M	-631.83M	-174.64M	-1.52B
Capital Expenditure	90.06M	211.94M	224.65M	221.46M	252.60M	394.51M	363.35M	401.19M	377.26M	1.09B	1.03B	1.40B	1.10B
Free Cash Flow	-38.16M	-446.92M	-892.96M	-62.30M	-207.57M	-58.47M	893.62M	722.88M	1.00B	-236.00M	863.11M	-497.45M	1.21B
Dividends Paid	402.82M	212.84M	1.04B	909.93M	232.89M	301.70M	266.39M	39.50M	458.57M	466.01M	424.33M	471.99M	524.22M
FCF to OCF	-73.51%	190.20%	133.61%	-39.14%	-461.04%	-17.40%	71.09%	64.31%	72.61%	-27.64%	45.66%	-54.99%	52.37%
Dividend Paid to FCF	-1055.71%	-47.62%	-116.20%	-1460.58%	-112.20%	-516.00%	29.81%	5.46%	45.84%	-197.46%	49.16%	-94.88%	43.20%

Earnings

Report Date	Oct 30, 2026
EPS Estimate	-
EPS Actual	-
Surprise	-
Timing	After-hours

Key Statistics & Ratios

Market Cap23.29B

Enterprise Value28.95B

Trailing P/E23.87

Forward P/E0.00

Price / Sales0.54

Price / Book4.04

EPS1.14

Book Value6.59

Revenue (TTM)42.83B

Gross Profit (TTM)9.41B

EBITDA2.29B

Profit Margin2.29%

Operating Margin3.38%

Return on Equity18.96%

Return on Assets5.79%

Shares Outstanding856.11M

Shares Float563.22M

Beta0.29

Dividend Yield1.17%

Dividend Rate0.32

Payout Ratio50.19%

Dividends

20261×

15.92Jun 17, 2026

20252×

29.42Nov 19, 202527.85Jun 18, 2025

20242×

26.98Nov 20, 202422.49Jun 19, 2024

20232×

23.24Nov 22, 202318.45Jun 7, 2023

20222×

28.12Nov 23, 202220.20Jun 8, 2022

20212×

19.49Nov 24, 202131.10Jun 9, 2021

20192×

12.79Nov 27, 201913.47Jun 5, 2019

20182×

20.70Oct 31, 201812.74May 23, 2018

20172×

18.73Nov 8, 20177.35May 31, 2017